Blood, gut and DNA testing in one connected hub built for pharmacies, aesthetics & beauty, medical practices and functional health, not just GP practices.
Prove whether your patients' supplements and medications are actually working, catch risks early, and build a recurring preventative-health service.
Bio Healthcare Hub gives UK pharmacists and providers the most advanced biomedical testing ecosystem blood, gut and DNA diagnostics in one intelligent system, with the largest range of biomarkers, streamlined reporting and seamless data access.
Identify metabolic, nutritional and genetic risks before symptoms appear turning your service into proactive, preventative care.
Act on clear insights early. Help patients avoid escalation, reduce long-term costs and stay healthier for longer.
Show patients whether their supplements and medications are genuinely working evidence, not guesswork, behind every recommendation.
Intelligent biomedical solutions that benefit your patients and your bottom line.

Healthier, happier patients and better outcomes that build loyalty and trust.

Better compliance and earlier detection mean lower long-term health costs.

Unlock new clinical and preventative-care revenue with evidence-based testing.

Recorded, evidence based outcomes that drive more revenue and repeat care.
Bio Healthcare Hub isn't just for pharmacies. Any business whose clients care about looking and feeling well can add connected blood, gut and DNA testing and prove real results.
Private testing, GLP-1 & supplement monitoring high-margin, no referral needed.
“Beauty from within” skin, hair & hormone testing that builds recurring revenue.
Preventative checks & deeper diagnostics better outcomes, new revenue.
Root-cause testing gut, hormones, nutrients & DNA in one hub.
Connected testing for your digital service kits & logistics handled.
Helping you build healthy eating habits with personalized nutrition guidance.
UK consumers are spending more than ever on supplements and private testing, while the NHS leans on community diagnostics and pharmacy services. That is a once-in-a-generation opening for pharmacists and providers to own preventative care.
The UK in-vitro diagnostics market is set to grow from ~£3.2bn (2025) to ~£4.6bn by 2030, with NHS Community Diagnostic Centres scaling fast.
UK dietary supplement spend is forecast to roughly double from ~£6.5bn (2025) to ~£13.5bn by 2035 yet most users never test if they work.
Demand for adult weight-management services in community pharmacy has risen 512% the largest increase of any community service.
Sources: Mordor Intelligence (UK IVD market, 2025–2030); Market Research Future (UK dietary supplements, 2025–2035); Nuffield Trust / The Pharmaceutical Journal (community pharmacy weight-management demand). Figures are forecasts, converted from USD at ~£0.74/$, and vary by methodology.
UK community pharmacy has proven it can deliver clinical services at scale the blood pressure check service alone has delivered over 7 million consultations. Pharmacists' core medicines expertise makes them ideally placed to run testing and support adherence.
A turnkey service menu pharmacists can offer in-store or online, fully supported by training, logistics and the Bio Healthcare Hub.
71% of UK adults take supplements yet almost none ever check whether they make a measurable difference. The same is true for many prescribed medications. Bio Healthcare Hub turns "I think it's helping" into proof.
Private GLP-1 use in the UK is booming typically £150–£300 per month, with the strongest uptake among women aged 30–49. Adherence is the challenge, and structured blood testing directly improves compliance, safety and outcomes exactly where pharmacists excel.
Best-practice monitoring for safety, adherence & outcomes. Labs are not mandatory to prescribe GLP-1s they are the quality differentiator. Not medical advice; clinical judgment applies.
GLP-1 is itself a gut hormone so the microbiome plays a major role in how patients respond, tolerate and maintain treatment. Adding gut testing turns a weight-loss prescription into a complete, connected programme.
Sources: MDPI Nutrients systematic review (2025); News-Medical / Diabetes In Control reviews (2026); STEP-5 & SELECT trials. The gut–GLP-1 field is emerging — much evidence is early or preclinical. Not medical advice; clinical judgment applies.
GLP-1 is just the start. The gut microbiome shapes how dozens of common medicines work from antibiotic recovery to cancer immunotherapy response giving pharmacists and clinicians a powerful new layer for prescribing, monitoring and lifestyle advice.

Guide recovery & smarter prescribing after antibiotics.
Why the same drug works for one patient, not another.
Monitor PPI use & support safe deprescribing.
Track how metformin, statins & BP drugs perform.
Inform nutrition advice for mood, sleep & stress.
Match diet & probiotics, then prove they worked.
Support HRT & hormones via the estrobolome.
Target acne, rosacea & eczema (gut–skin axis).
Explain variable levothyroxine response.
Protect the gut from NSAIDs & opioids.
Guide allergy, eczema & immune-resilience advice.
Linked to colorectal risk & immunotherapy response.
Explain why Parkinson’s levodopa response varies.
Target & track fatty liver (MASLD).
Precision diet advice for prediabetes & diabetes.
Support metabolism & recovery for performance.
A powerful new layer for medicines reviews.
Guide treatment choices in inflammatory bowel disease.
Sources: Weersma et al., Gut (drug–microbiome interactions); Bolte et al., Gastroenterology 2025 (pharmacomicrobiomics & immunotherapy); Biocodex Microbiota Institute review (2025); Salem et al., Frontiers in Microbiology & Mahmud et al., Gut Microbes (gut–skin axis); estrobolome / menopause reviews; Parkinson's & levodopa studies (Frontiers/NCBI); Nature Communications (NAFLD, exercise & diet); Zeevi et al., Cell (personalised glucose response). An emerging field not medical advice; clinical judgment applies.


A one time DNA test is the blueprint for truly personalised care revealing how patients respond to medications and nutrients, and where to focus prevention. With MyDNA Clinic™, genetics becomes a practical, everyday tool.
DNA insights support, not replace, clinical judgment. Not medical advice.
From single practitioners to large clinics our platform fits seamlessly into every specialty.
Marketing, SEO, technology and point-of-care solutions that help providers deliver better care, build stronger brands and increase revenue per patient.
We help you and your team deliver testing services efficiently with full training and education.
Top-tier, cost-effective logistics for delivering testing kits and collecting samples for the labs.
World-class lab testing with clear, accessible reports that are easy for everyone to understand.
Point-of-care and online marketing resources to support your launch and boost your revenue.
Manage your patients and their Blood, Gut and DNA testing reports in one secure place everything you need to run testing effortlessly.
Both. The platform is designed for pharmacists and independent prescribers as well as GPs and clinics pharmacists' medicines expertise and footfall make them ideally placed to run preventative testing and support adherence.
We measure the relevant biomarker at baseline, the patient starts (or continues) their supplement or medicine, and we re-test at 8–12 weeks. The change proves whether it's having a measurable effect turning guesswork into evidence and reducing wasted spend.
Blood testing, gut health (KnowMyGut™), DNA & genetic testing, pharmacogenomics, GLP-1 / weight-loss monitoring and Cancer BioCare™ all integrated into one connected platform.
Yes. The Hub is fully UK GDPR compliant. All data is encrypted, securely stored and never shared without explicit consent.
We provide cost-effective logistics for delivering testing kits and collecting samples for return to our accredited UK labs.
Join the UK's preventative-health testing network and give your patients evidence, not guesswork. Built for pharmacists and providers alike.
Partner With Us